// App-Quantinova.ai

: Synovial fluid fingerprinting in end-stage knee osteoarthritis: a novel biomarker concept to assess disease modifying therapies

Researchers

Presenter

  • C. Jayadev

Principal Investigators

  • P. Hulley

  • S. Snelling

  • C. Swales

  • G. Collins

  • F. Germaschewski

  • P. Taylor

  • A. Price

Medical Centers

  • Nuffield Dept. of Orthopaedics, Rheumatology, and Musculoskeletal Sci., Univ. of Oxford, Oxford, United Kingdom

  • Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom

  • GlaxoSmithKline Biopharmaceutical Res. & Dev., Stevenage, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Knee osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved